Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom

Summary This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88–90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. Improved post-fracture care is need...

Full description

Bibliographic Details
Main Authors: Skjødt, MK, Khalid, S, Ernst, M, Rubin, KH, Martinez-Laguna, D, Delmestri, A, Javaid, MK, Cooper, C, Libanati, C, Toth, E, Abrahamsen, B, Prieto-Alhambra, D
Format: Journal article
Language:English
Published: Springer Nature 2020
_version_ 1797059686800818176
author Skjødt, MK
Khalid, S
Ernst, M
Rubin, KH
Martinez-Laguna, D
Delmestri, A
Javaid, MK
Cooper, C
Libanati, C
Toth, E
Abrahamsen, B
Prieto-Alhambra, D
author_facet Skjødt, MK
Khalid, S
Ernst, M
Rubin, KH
Martinez-Laguna, D
Delmestri, A
Javaid, MK
Cooper, C
Libanati, C
Toth, E
Abrahamsen, B
Prieto-Alhambra, D
author_sort Skjødt, MK
collection OXFORD
description Summary This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88–90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. Improved post-fracture care is needed. <br><br> Introduction Patients experiencing a fragility fracture are at high risk of subsequent fractures, particularly within the first 2 years after the fracture. Previous studies have demonstrated that only a small proportion of fracture patients initiate therapy with an anti-osteoporotic medication (AOM), despite the proven fracture risk reduction of such therapies. The aim of this paper is to evaluate the changes in this post-fracture treatment gap across three different countries from 2005 to 2015. <br><br> Methods This analysis, which is part of a multinational cohort study, included men and women, aged 50 years or older, sustaining a first incident fragility fracture. Using routinely collected patient data from three administrative health databases covering Catalonia, Denmark, and the United Kingdom, we estimated the treatment gap as the proportion of patients not treated with AOM within 1 year of their first incident fracture. <br><br> Results A total of 648,369 fracture patients were included. Mean age 70.2–78.9 years; 22.2–31.7% were men. In Denmark, the treatment gap was stable at approximately 88–90% throughout the 2005 to 2015 time period. In Catalonia, the treatment gap increased from 80 to 88%. In the UK, an initially decreasing treatment gap—though never smaller than 63%—was replaced by an increasing gap towards the end of our study. The gap was more pronounced in men than in women. <br><br> Conclusion Despite repeated calls for improved secondary fracture prevention, an unacceptably large treatment gap remains, with time trends indicating that the problem may be getting worse in recent years.
first_indexed 2024-03-06T20:07:44Z
format Journal article
id oxford-uuid:297912e2-eeff-4cdc-a9ff-9cd9e3a78ac4
institution University of Oxford
language English
last_indexed 2024-03-06T20:07:44Z
publishDate 2020
publisher Springer Nature
record_format dspace
spelling oxford-uuid:297912e2-eeff-4cdc-a9ff-9cd9e3a78ac42022-03-26T12:19:22ZSecular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United KingdomJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:297912e2-eeff-4cdc-a9ff-9cd9e3a78ac4EnglishSymplectic ElementsSpringer Nature2020Skjødt, MKKhalid, SErnst, MRubin, KHMartinez-Laguna, DDelmestri, AJavaid, MKCooper, CLibanati, CToth, EAbrahamsen, BPrieto-Alhambra, DSummary This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88–90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. Improved post-fracture care is needed. <br><br> Introduction Patients experiencing a fragility fracture are at high risk of subsequent fractures, particularly within the first 2 years after the fracture. Previous studies have demonstrated that only a small proportion of fracture patients initiate therapy with an anti-osteoporotic medication (AOM), despite the proven fracture risk reduction of such therapies. The aim of this paper is to evaluate the changes in this post-fracture treatment gap across three different countries from 2005 to 2015. <br><br> Methods This analysis, which is part of a multinational cohort study, included men and women, aged 50 years or older, sustaining a first incident fragility fracture. Using routinely collected patient data from three administrative health databases covering Catalonia, Denmark, and the United Kingdom, we estimated the treatment gap as the proportion of patients not treated with AOM within 1 year of their first incident fracture. <br><br> Results A total of 648,369 fracture patients were included. Mean age 70.2–78.9 years; 22.2–31.7% were men. In Denmark, the treatment gap was stable at approximately 88–90% throughout the 2005 to 2015 time period. In Catalonia, the treatment gap increased from 80 to 88%. In the UK, an initially decreasing treatment gap—though never smaller than 63%—was replaced by an increasing gap towards the end of our study. The gap was more pronounced in men than in women. <br><br> Conclusion Despite repeated calls for improved secondary fracture prevention, an unacceptably large treatment gap remains, with time trends indicating that the problem may be getting worse in recent years.
spellingShingle Skjødt, MK
Khalid, S
Ernst, M
Rubin, KH
Martinez-Laguna, D
Delmestri, A
Javaid, MK
Cooper, C
Libanati, C
Toth, E
Abrahamsen, B
Prieto-Alhambra, D
Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
title Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
title_full Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
title_fullStr Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
title_full_unstemmed Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
title_short Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
title_sort secular trends in the initiation of therapy in secondary fracture prevention in europe a multi national cohort study including data from denmark catalonia and the united kingdom
work_keys_str_mv AT skjødtmk seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
AT khalids seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
AT ernstm seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
AT rubinkh seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
AT martinezlagunad seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
AT delmestria seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
AT javaidmk seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
AT cooperc seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
AT libanatic seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
AT tothe seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
AT abrahamsenb seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
AT prietoalhambrad seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom